Gelonghui September 26th | Guoke Hengtai (301370.SZ) stated at an investor relations event that aging and urbanization will jointly drive the continuous growth of china's medical device demand. As the population peak born in the mid-20th century gradually enters the elderly stage, the early 21st century will be the fastest period of aging in China. By 2023, china's population aged 65 and above is 0.217 billion, accounting for 15.4% of the national population, with an increase of 7.91 million elderly people more than the newborns. (Source: National Bureau of statistics) According to the United Nations Population Fund, by 2030, the number of people aged 65 and above in china will reach 0.272 billion, accounting for 19.4% of the national population, indicating that the aging of the population is in a rapidly deepening stage. With accelerated aging, the incidence of chronic diseases such as cardiovascular diseases, hypertension, neurological diseases, and orthopedic diseases will increase significantly, leading to an increased demand for medical devices. In addition, the rapid development of urbanization will continue to release the medical needs of the rural elderly population. According to the data of the National Bureau of statistics, china's urbanization rate at the end of 2023 was 66.16%, still in a rapid development range. Compared to the average urbanization rate of 80% in developed countries in Europe and America, there is enormous potential for future improvement. Our company is a digital supply chain comprehensive service provider focusing on the distribution of medical devices. Among the medical devices currently sold by the company, high-value consumables such as cardiovascular intervention, orthopedics, neurosurgery, and rehabilitation are suitable for the elderly patient population.